Mid-Atlantic Retina — Bethlehem, Pennsylvania

Mid-Atlantic Retina is a clinical research site located in Bethlehem, Pennsylvania, United States 18017.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid-Atlantic Retina has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Nonproliferative Diabetic Retinopathy, Geographic Atrophy of the Macula, Macular Degeneration.

Sponsors: EyePoint Pharmaceuticals, Inc., Aviceda Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Atlantic Retina?

Mid-Atlantic Retina has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Atlantic Retina conducted?

Mid-Atlantic Retina has 2 clinical trials on record, with 1 currently active. Their work covers Nonproliferative Diabetic Retinopathy, Geographic Atrophy of the Macula, Macular Degeneration.

Is Mid-Atlantic Retina accredited by Crixeo Health?

Mid-Atlantic Retina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Atlantic Retina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.